The immunobiological production unit of NPO Petrovax Pharm, a Russian pharmaceutical company, has produced more than 2.5 mln doses of Prevenar 13, a 13-valent conjugate pneumococcal vaccine, in easy to use disposable auto injectors. More than 5 mln doses are planned to be produced by the end of 2014.